Delver (λΈλ²) intensively develops in-licensed biotechnology in CMC/quality, non-clinical and clinical aspects to increase value and conduct high-value-added business to out-license to global big pharma.
Read more β
Tired of ads? Enjoy an ad-free experience by signing up.
Unlock unlimited company data
Already a subscriber? Log in.
Our subscriber community includes professionals from these companies:
Similar companies
Tired of ads? Enjoy an ad-free experience by signing up.